Nordic Nanovector ASA: Mandatory notification of trade - primary insider - correction

Fri, Aug 23, 2019 14:56 CET

With reference to the previous notification of trade, the correct number of shares purchased today, 23 August 2019, by Malene Brondberg is not 1,722 shares, but 3,900 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 25.38 per share. Following this transaction, Malene Brondberg owns 9,455 shares in the Company and holds 40,000 PSUs.

This information is subject to duty of disclosure pursuant to Section 4-2 and Section 5-2 of the Norwegian Securities Trading Act.

Tags:

Cancer Therapy non-hodgkins lymphoma Betalutin Nordic Nanovector Radioimmunotherapy Roy Hartvig Larsen anticancer therapeutics

Nordic Nanovector ASA: Mandatory notification of trade - primary insider - correction

Subscribe